Postoperative Oral Dexamethasone and Pediatric Tonsillectomy Morbidity: A Randomized Clinical Trial

Amber D Shaffer1, Mahmoud Omar2,3, Raymond C Maguire1

  • 1Division of Pediatric Otolaryngology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.

Insights

Postoperative oral dexamethasone may modestly reduce pain after pediatric adenotonsillectomy. This steroid use also significantly decreased opioid prescriptions and emergency department visits for pain without increasing complications.

Area of Science:

  • Otolaryngology
  • Pediatric Surgery
  • Pharmacology

Background:

  • Tonsillectomy is a highly painful procedure for children.
  • The effectiveness of postoperative oral steroids in managing pediatric tonsillectomy pain and related complications is not well-established.

Purpose of the Study:

  • To evaluate the efficacy of postoperative oral dexamethasone in reducing pain and morbidity following pediatric adenotonsillectomy.

Main Methods:

  • A quadruple-blinded, randomized clinical trial involving pediatric patients (3-17 years) undergoing adenotonsillectomy.
  • Participants received either oral dexamethasone or a placebo on postoperative days 2, 4, and 6.
  • Pain scores, adverse events, and healthcare utilization were monitored for up to 9 weeks.

Main Results:

  • The dexamethasone group showed a trend towards lower mean pain scores (0.72 points less) on days 2-8, though not statistically definitive.
  • Significant reductions were observed in opioid prescriptions (OR 0.23) and emergency department visits for pain (OR 0.12) in the dexamethasone group.
  • No significant differences were found in readmissions, calls to nurses, post-tonsillectomy hemorrhage, or return to a normal diet.

Conclusions:

  • Postoperative oral dexamethasone appears to be a safe analgesic adjunct for pediatric adenotonsillectomy.
  • It is associated with a modest reduction in pain and a significant decrease in opioid use and pain-related ED visits.
  • Further research with enhanced precision is needed to confirm pain reduction findings.
Abstract